Endovascular Thrombectomy of Calcified Emboli in Acute Ischemic Stroke: A Multicenter Study.


Journal

AJNR. American journal of neuroradiology
ISSN: 1936-959X
Titre abrégé: AJNR Am J Neuroradiol
Pays: United States
ID NLM: 8003708

Informations de publication

Date de publication:
03 2020
Historique:
received: 05 10 2019
accepted: 23 12 2019
pubmed: 8 2 2020
medline: 21 10 2020
entrez: 8 2 2020
Statut: ppublish

Résumé

Large intracranial vessel occlusion due to calcified emboli is a rare cause of major stroke. We assessed the prevalence, imaging appearance, the effectiveness of mechanical thrombectomy, and clinical outcome of patients with large-vessel occlusion due to calcified emboli. We performed a retrospective analysis of clinical and procedural data of consecutive patients who underwent mechanical thrombectomy due to calcified emboli in 7 European stroke centers. We screened 2969 patients, and 40 patients matched the inclusion criteria, accounting for a prevalence of 1.3%. The mean maximal density of the thrombus was 327 HU (range, 150-1200 HU), and the mean thrombus length was 9.2 mm (range, 4-20 mm). Four patients had multiple calcified emboli, and 2 patients had an embolic event during an endovascular intervention. A modified TICI score of ≥2b was achieved in 57.5% (23/40), with minimal-to-no reperfusion (modified TICI 0-1) in 32.5% (13/40) and incomplete reperfusion (modified TICI 2a) in 10% (4/40). Excellent outcome (mRS 0-1) was achieved in only 20.6%, functional independence (mRS 0-2) in 26.5% and 90-day mortality was 55.9%. Acute ischemic stroke with large-vessel occlusion due to calcified emboli is a rare entity in patients undergoing thrombectomy, with considerably worse angiographic outcome and a higher mortality compared with patients with noncalcified thrombi. Good functional recovery at 3 months can still be achieved in about a quarter of patients.

Sections du résumé

BACKGROUND AND PURPOSE
Large intracranial vessel occlusion due to calcified emboli is a rare cause of major stroke. We assessed the prevalence, imaging appearance, the effectiveness of mechanical thrombectomy, and clinical outcome of patients with large-vessel occlusion due to calcified emboli.
MATERIALS AND METHODS
We performed a retrospective analysis of clinical and procedural data of consecutive patients who underwent mechanical thrombectomy due to calcified emboli in 7 European stroke centers.
RESULTS
We screened 2969 patients, and 40 patients matched the inclusion criteria, accounting for a prevalence of 1.3%. The mean maximal density of the thrombus was 327 HU (range, 150-1200 HU), and the mean thrombus length was 9.2 mm (range, 4-20 mm). Four patients had multiple calcified emboli, and 2 patients had an embolic event during an endovascular intervention. A modified TICI score of ≥2b was achieved in 57.5% (23/40), with minimal-to-no reperfusion (modified TICI 0-1) in 32.5% (13/40) and incomplete reperfusion (modified TICI 2a) in 10% (4/40). Excellent outcome (mRS 0-1) was achieved in only 20.6%, functional independence (mRS 0-2) in 26.5% and 90-day mortality was 55.9%.
CONCLUSIONS
Acute ischemic stroke with large-vessel occlusion due to calcified emboli is a rare entity in patients undergoing thrombectomy, with considerably worse angiographic outcome and a higher mortality compared with patients with noncalcified thrombi. Good functional recovery at 3 months can still be achieved in about a quarter of patients.

Identifiants

pubmed: 32029470
pii: ajnr.A6412
doi: 10.3174/ajnr.A6412
pmc: PMC7077917
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

464-468

Informations de copyright

© 2020 by American Journal of Neuroradiology.

Références

J Neurointerv Surg. 2017 Jun;9(6):529-534
pubmed: 27166383
J Neurointerv Surg. 2019 Jul;11(7):675-682
pubmed: 30415225
N Engl J Med. 2015 Jan 1;372(1):11-20
pubmed: 25517348
Neurosurgery. 2008 Jul;63(1):E180-1; discussion E181
pubmed: 18728560
Stroke. 1999 Nov;30(11):2280-4
pubmed: 10548658
J Neuroimaging. 2004 Oct;14(4):385-7
pubmed: 15358964
J Neurosurg. 2010 Mar;112(3):557-62
pubmed: 19764826
Rofo. 2004 Jan;176(1):98-105
pubmed: 14712413
J Am Heart Assoc. 2018 Dec 18;7(24):e010867
pubmed: 30561262
Stroke. 2013 Apr;44(4):1166-8
pubmed: 23412375
Pract Neurol. 2017 Aug;17(4):307-309
pubmed: 28659455
AJNR Am J Neuroradiol. 2014 Aug;35(8):1515-9
pubmed: 24651819
J Neurointerv Surg. 2018 Jun;10(6):525-529
pubmed: 28963362
Lancet. 2016 Apr 23;387(10029):1723-31
pubmed: 26898852
J Stroke Cerebrovasc Dis. 2017 Oct;26(10):2050-2054
pubmed: 28712720
J Neurointerv Surg. 2015 Feb;7(2):104-7
pubmed: 24510378
J Neurointerv Surg. 2018 Jan;10(1):34-38
pubmed: 28044009
J Med Imaging Radiat Oncol. 2018 Apr 17;:
pubmed: 29665308
Interv Neuroradiol. 2018 Dec;24(6):674-677
pubmed: 29969958
Eur Stroke J. 2017 Jun;2(2):95-102
pubmed: 29900406
AJNR Am J Neuroradiol. 2016 May;37(5):838-43
pubmed: 26611995
Neurologia. 2017 May;32(4):270-273
pubmed: 26304657
J Clin Neurosci. 2018 Jan;47:56-61
pubmed: 29102234
Stroke. 2018 Apr;49(4):958-964
pubmed: 29581342
Eur Radiol. 2016 Jun;26(6):1742-50
pubmed: 26370945
J Am Coll Cardiol. 1990 Mar 15;15(4):827-32
pubmed: 2407762
J Neurointerv Surg. 2014 Jun;6(5):363-72
pubmed: 23821672
AJNR Am J Neuroradiol. 2018 May;39(5):887-891
pubmed: 29567654
AJNR Am J Neuroradiol. 2012 Jun;33(6):1156-61
pubmed: 22322606
J Stroke Cerebrovasc Dis. 2017 Jan;26(1):e5-e7
pubmed: 27789151
J Stroke Cerebrovasc Dis. 2001 May-Jun;10(3):135-8
pubmed: 17903815
J Stroke. 2015 Jan;17(1):67-75
pubmed: 25692109
J Neurointerv Surg. 2018 Nov;10(11):1121-1126
pubmed: 30154252
J Neurointerv Surg. 2018 Apr;10(4):345-350
pubmed: 28798266

Auteurs

C J Maurer (CJ)

From the Departments of Diagnostic and Interventional Radiology and Neuroradiology (C.J.M., F.J., A.Berlis) Christoph.Maurer@uk-augsburg.de.

T Dobrocky (T)

University Institute of Diagnostic and Interventional Neuroradiology (T.Dobrocky, J.G.), University of Bern, Inselspital, Bern, Switzerland.

F Joachimski (F)

From the Departments of Diagnostic and Interventional Radiology and Neuroradiology (C.J.M., F.J., A.Berlis).

U Neuberger (U)

Department of Neuroradiology (U.N., M.A.M.), University of Heidelberg, Heidelberg, Germany.

T Demerath (T)

Department of Neuroradiology (T.Demerath, A.Brehm, K.A.B., M.N.P.), Clinic of Radiology and Nuclear Medicine, University Hospital Basel, Basel, Switzerland.

A Brehm (A)

Department of Neuroradiology (T.Demerath, A.Brehm, K.A.B., M.N.P.), Clinic of Radiology and Nuclear Medicine, University Hospital Basel, Basel, Switzerland.
Department of Neuroradiology (A.Brehm, M.N.P.), University Medical Center Göttingen, Göttingen, Germany.

A Cianfoni (A)

Department of Neuroradiology (A.C.), Neurocenter of Southern Switzerland, Lugano, Switzerland.

B Gory (B)

Department of Diagnostic and Therapeutic Neuroradiology (B.G.), University Hospital of Nancy, Institut National de la Santé et de la Recherche Médicale U1254, Nancy, France.

A Berlis (A)

From the Departments of Diagnostic and Interventional Radiology and Neuroradiology (C.J.M., F.J., A.Berlis).

J Gralla (J)

University Institute of Diagnostic and Interventional Neuroradiology (T.Dobrocky, J.G.), University of Bern, Inselspital, Bern, Switzerland.

M A Möhlenbruch (MA)

Department of Neuroradiology (U.N., M.A.M.), University of Heidelberg, Heidelberg, Germany.

K A Blackham (KA)

Department of Neuroradiology (T.Demerath, A.Brehm, K.A.B., M.N.P.), Clinic of Radiology and Nuclear Medicine, University Hospital Basel, Basel, Switzerland.

M N Psychogios (MN)

Department of Neuroradiology (T.Demerath, A.Brehm, K.A.B., M.N.P.), Clinic of Radiology and Nuclear Medicine, University Hospital Basel, Basel, Switzerland.
Department of Neuroradiology (A.Brehm, M.N.P.), University Medical Center Göttingen, Göttingen, Germany.

P Zickler (P)

Neurology and Neurophysiology (P.Z.), Universitätsklinikum Augsburg, Augsburg, Germany.

S Fischer (S)

Institut für Diagnostische und Interventionelle Radiologie, Neuroradiologie (S.F.), Nuklearmedizin, Knappschaftskrankenhaus Bochum-Langendreer, Universitätsklinik, Bochum, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH